Stage IV BRCA1 Ovarian Cancer: Lauren's Patient Story

Patient Info: Lauren Corduck, Female | Stage IV

Biomarkers: BRCA1 mutation

Metastatic Site: lymph nodes, including a node near the left collarbone

Lauren was diagnosed with recurrent ovarian cancer in December 2017 and was undergoing chemotherapy, with a PARP inhibitor planned as the next treatment step.

Massachusetts General HospitalRead more →

Stage II Ovarian Cancer: Dana's Survivor Story

Patient Info: Dana McKay | Stage II

After surgery and 6 rounds of carboplatin and paclitaxel, she described herself as cancer-free in February 2019.

MD AndersonRead more →

Ovarian Cancer: Vilma's Patient Story

Patient Info: Vilma Rosario

After surgery and 6 chemotherapy treatments for ovarian cancer, Vilma was recovering and moving forward with her family and marriage plans.

Memorial Sloan KetteringRead more →

Stage I Ovarian Cancer: Jane's Survivor Story

Patient Info: Jane McGrath, female, 40s | Stage I

Jane was in remission after surgery and 6 rounds of chemotherapy and later became an ovarian-cancer volunteer and advocate.

Memorial Sloan KetteringRead more →

Stage IV Ovarian Cancer: Manisha's Survivor Story

Patient Info: Manisha Koirala, Female | Stage IV

She was declared cancer-free after her final chemotherapy cycle on April 30, 2013, and remained in remission more than 6 years later.

Memorial Sloan KetteringRead more →

Ovarian Cancer: Bryn's Survivor Story

Patient Info: Bryn Cloud, Female

Biomarkers: Unnamed somatic tumor-cell mutation identified; no hereditary cancer mutation found

Bryn became a survivor after surgery that removed a 10-pound dysgerminoma tumor, fertility preservation, genomic testing, and 4 rounds of intensive chemotherapy.

City of HopeRead more →

Stage II Ovarian Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth Jardinella, Female, Under 40 | Stage II

Cancer-free for about 2 years, with surveillance scans continuing to show no evidence of disease while she takes maintenance letrozole.

MD AndersonRead more →

Early-stage ovarian squamous cell carcinoma arising in a mature cystic teratoma

Patient Info: Anonymized, female, 50s | Stage I

Biomarkers: ovarian tumor HPV DNA-negative; p16-negative

She achieved complete remission and had no evidence of recurrence 24 months after surgery, at follow-up in June 2026.

PubMed CentralRead more →

Rare ovarian cancer diagnosed during pregnancy after an initial misdiagnosis

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: SMARCA4 and TP53 alterations

Metastatic Site: liver|spleen|bone

After a complete response in July 2024, the cancer recurred widely within about 6 months. She died from progressive disease in January 2025.

PubMed CentralRead more →

Ovarian Cancer: Robyn's Survivor Story

Patient Info: Robyn Townsend

After surgery, 6 rounds of chemotherapy and ongoing olaparib, she reported no evidence of disease since the previous December.

MD AndersonRead more →

Growing teratoma syndrome after ovarian germ cell tumor treatment: Case 1

Patient Info: Anonymized, Female, Under 40

Biomarkers: AFP and beta-hCG elevated

Five months after completing therapy, her tumor markers were normal and there was no evidence of disease.

PubMed CentralRead more →

Growing teratoma syndrome after ovarian germ cell tumor treatment: Case 2

Patient Info: Anonymized, Female, Under 40 | Stage III

Biomarkers: AFP and beta-hCG elevated

After surgery and completion of chemotherapy in January 2025, she was without disease and her tumor markers were normal.

PubMed CentralRead more →

Stage II Ovarian Squamous Cell Carcinoma: Caitlin's Survivor Story

Patient Info: Caitlin Koehler, female, Under 40 | Stage II

Biomarkers: PD-L1: high expression

After surgery for recurrence, Caitlin remained on maintenance therapy and her follow-up scans showed no evidence of disease.

MD AndersonRead more →

Stage IV Ovarian Cancer First Found Through an Umbilical Metastasis

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: WT1-positive; CK7-positive; CA-125 321 U/mL at diagnosis

Metastatic Site: umbilicus

After 9 months of bevacizumab maintenance, her clinical and imaging findings remained stable.

PubMed CentralRead more →

Eight years cancer-free after treatment for a rare ovarian Brenner tumor

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: High Ki-67

At 8-year follow-up, surveillance showed no clinical or radiologic evidence of disease.

PubMed CentralRead more →

Durable response after multiple treatments for ovarian clear cell cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: HRD-positive; BRCA-negative; ARID1A mutation; PD-L1 CPS 30

She achieved a complete response, completed maintenance immunotherapy in May 2024, and continued anlotinib with normal follow-up imaging and tumor markers.

PubMed CentralRead more →

Ovarian Cancer: Hope's Patient Story

Patient Info: Hope Aguilar, female

More than 14 years after her December 2011 diagnosis, Hope is a survivor and advocate after initial treatment and a later ovarian-cancer recurrence.

Ovarian Cancer Remission Before Zolpidem Withdrawal Delirium

Patient Info: Anonymized, female

The ovarian cancer had not recurred for about 6 years, and she remained in remission.

PubMed CentralRead more →

Ovarian Cancer Metastatic to an Axillary Lymph Node Without Breast Disease

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: BRCA1/2 negative

Metastatic Site: right axillary lymph node

Secondary cytoreductive surgery in April 2025 achieved complete macroscopic cytoreduction, and she was discharged without complications.

PubMed CentralRead more →

Ovarian Cancer Surgery Complicated by Infective Endocarditis After Splenectomy

Patient Info: Anonymized, female, 50s

After ovarian-cancer surgery, she developed intestinal obstruction and infective endocarditis and later died from septicemia.

PubMed CentralRead more →

Ovarian Cancer Remission With Olaparib After Chemotherapy Intolerance

Patient Info: Anonymized, female, 50s | Stage III

Biomarkers: germline BRCA1 mutation

At 48 months, imaging showed complete remission and CA125 was normal while she continued reduced-dose olaparib.

PubMed CentralRead more →

Young Woman With Rare Small Cell Ovarian Cancer and Abdominal Recurrence

Patient Info: Anonymized, female, Under 40 | Stage III

Biomarkers: loss of SMARCA4 expression; retained SMARCB1 expression

The recurrent cancer continued to progress despite further chemotherapy, and she died at home 26 months after the initial diagnosis.

PubMed CentralRead more →

Stage I Immature Ovarian Teratoma With a Benign Teratoma in the Other Ovary

Patient Info: Anonymized, female, Under 40 | Stage I

Biomarkers: AFP 90 ng/mL at diagnosis; CA-125 within normal range

Follow-up imaging showed no recurrence, and she remained well under regular oncologic surveillance after chemotherapy was stopped early.

PubMed CentralRead more →

Stage IV Ovarian Cancer: Evelyn's Survivor Story

Patient Info: Evelyn, female | Stage IV

Biomarkers: HRD-positive

After chemotherapy and surgery, Evelyn reported an unremarkable final scan in May 2023 and then completed 2 years of Lynparza maintenance therapy guided by HRD-positive tumor testing.